An Overview of Insulin Pumps and Glucose Sensors for the Generalist

An Overview of Insulin Pumps and Glucose Sensors for the Generalist

Continuous subcutaneous insulin, or the insulin pump, has gained popularity and sophistication as a near-physiologic programmable method of insulin delivery that is flexible and lifestyle-friendly. The introduction of continuous monitoring with glucose sensors provides unprecedented access to, and p...

Full description

Bibliographic Details
Main Authors:	Brooke H. McAdams, Ali A. Rizvi
Format:	Article
Language:	English
Published:	MDPI AG 2016-01-01
Series:	Journal of Clinical Medicine
Subjects:	diabetes insulin pump pancreas glucose sensor monitoring
Online Access:	http://www.mdpi.com/2077-0383/5/1/5

Similar Items

Combining continuous glucose monitoring and insulin pumps to automatically tune the basal insulin infusion in diabetes therapy: a review
by: Martina Vettoretti, et al.
Published: (2019-03-01)

Patch Testing with Isobornyl Acrylate in 16 Swedish Patients with Contact Dermatitis from Glucose Sensors and/or Insulin Pumps
by: Martin Mowitz, et al.
Published: (2019-10-01)

Effect of use of insulin pump with low glucose suspend feature on metabolic control in children with type 1diabetes
by: Gordana Bukara-Radujković, et al.
Published: (2018-07-01)

The insulin pump therapy in type 1 Diabetes: The importance of glucose variability
by: Jozić Jovan, et al.
Published: (2019-01-01)

Optimizing User Experience in Insulin Pump Therapy by Applying The Attributes of Fitness and Wellness Monitoring Systems
by: Li, Yanhan
Published: (2015)

THE MECHANISM OF GLUCOSE-INDUCED INSULIN SECRETION OF 2,4-DIAMINO-5-CYANO-6-BROMOPYRIDINE IN RAT PANCREAS ISLETS.
by: McCreary, Jane Ann Hogan.
Published: (1983)

Intraperitoneal insulin infusion: on the way to the artificial pancreas
by: Vladimir Aleksandrovich Karpel'ev, et al.
Published: (2015-06-01)

Long-Term Effects of Initiating Continuous Subcutaneous Insulin Infusion (CSII) and Continuous Glucose Monitoring (CGM) in People with Type 1 Diabetes and Unsatisfactory Diabetes Control
by: Jon-Duri Senn, et al.
Published: (2019-03-01)

The insulin pump for you(th)
by: Lind, Jenny, et al.
Published: (2006)

Modeling the Error of the Medtronic Paradigm Veo Enlite Glucose Sensor
by: Lyvia Biagi, et al.
Published: (2017-06-01)

THE STATE AND FUTURE OF CLOSED LOOP INSULIN PUMPS / ARTIFICIAL PANCREAS
by: Umapathy, Chandravadhana
Published: (2011)

Selected aspects of insulin pump therapy and continuous glucose monitoring in real time (in relation to the letter of E.D.Gorbachev)
by: Yury Ivanovich Filippov, et al.
Published: (2010-12-01)

Fingerprint Access Control for Wireless Insulin Pump Systems Using Cancelable Delaunay Triangulations
by: Guanglou Zheng, et al.
Published: (2019-01-01)

Effect of dietary fiber and carbohydrate source on glucose tolerance, insulin response and lipogenic enzyme activity
by: Davis, Venette Kolman
Published: (2011)

A control of glucose level in insulin therapies for the development of artificial pancreas by Atangana Baleanu derivative
by: Muhammad Farman, et al.
Published: (2020-08-01)

Leptin therapy, insulin sensitivity, and glucose homeostasis
by: Gilberto Paz-Filho, et al.
Published: (2012-01-01)

Modulation of Insulin Sensitivity by Insulin-Degrading Enzyme
by: Carlos M. González-Casimiro, et al.
Published: (2021-01-01)

Calibration of Minimally Invasive Continuous Glucose Monitoring Sensors: State-of-The-Art and Current Perspectives
by: Giada Acciaroli, et al.
Published: (2018-03-01)

Cost-effectiveness of sensor-augmented insulin pump therapy vs continuous subcutaneous insulin infusion in patients with type 1 diabetes in the Netherlands
by: Roze S, et al.
Published: (2019-01-01)

Effect of real‐life insulin pump with predictive low‐glucose management use for 3 months: Analysis of the patients treated in a Japanese center
by: Asako Tsunemi, et al.
Published: (2020-11-01)

Comparison of rechargeable versus battery-operated insulin pumps: temperature fluctuations
by: Vereshchetin P, et al.
Published: (2016-10-01)

An investigation of acute effects at various doses of malathion on glucose homeostasis and insulin resistance in rat liver, pancreas and serum
by: Murat Ekremoğlu, et al.
Published: (2020-04-01)

The Automatic Regulation of the Basal Dose on the Insulin Pump for the Treatment of Patients that have Diabetes Type 1
by: Sifet Mehanović, et al.
Published: (2010-05-01)

Dose adjustment in insulin pump therapy: optimization of bolus calculator settings
by: Yury Ivanovich Filippov, et al.
Published: (2012-09-01)

Evolving use of continuous glucose monitoring beyond intensive insulin treatment
by: Subramanian, S., et al.
Published: (2021)

Use of an Insulin Pump in the Elderly Surgical Patient: Tolerance of Total Pancreatectomy After Neoadjuvant Chemotherapy for Multifocal Pancreatic Cancer
by: Andrew McGregor, et al.
Published: (2018-10-01)

Continuous glucose monitoring in the ICU: clinical considerations and consensus
by: James S. Krinsley, et al.
Published: (2017-07-01)

Feasibility Design of a Continuous Insulin Sensor from Lessons Learned using Glucose Sensors, and Point of Care Insulin Sensors
Published: (2018)

Long-Term Glucose Forecasting Using a Physiological Model and Deconvolution of the Continuous Glucose Monitoring Signal
by: Chengyuan Liu, et al.
Published: (2019-10-01)

Assessment of endogenous insulin secretion in insulin treated diabetes predicts postprandial glucose and treatment response to prandial insulin
by: Jones Angus G, et al.
Published: (2012-06-01)

Trefoil factor 3 (TFF3) expression is regulated by insulin and glucose
by: Girolamo Jose Barrera Roa, et al.
Published: (2013-04-01)

Trefoil factor 3 (TFF3) expression is regulated by insulin and glucose
by: Jose Barrera Roa, et al.
Published: (2013-04-01)

The neuropeptide 26RFa in the human gut and pancreas: potential involvement in glucose homeostasis
by: Gaëtan Prévost, et al.
Published: (2019-07-01)

Hypoglycemia in type 2 diabetes patients treated with insulin: the advantages of continuous glucose monitoring
by: Vadim Valer'evich Klimontov, et al.
Published: (2014-03-01)

Insulin pump therapy and continuous glucose monitoring in adults with type 2 diabetes: where are we now?
by: Erika Pedone, et al.
Published: (2020-10-01)

Reported insulin pump temperature fluctuations lack clinical relevance
by: Dokken BB, et al.
Published: (2017-02-01)

Telemedicine in the Time of the COVID-19 Pandemic: Results from the First Survey among Italian Pediatric Diabetes Centers
by: Gianluca Tornese, et al.
Published: (2021-06-01)

Nocturnal Hypoglycemia – The Main Indication for Insulin Pump Therapy in Adulthood
by: Maja Baretić, et al.
Published: (2016-01-01)

The Benefits and Limits of Technological Advances in Glucose Management Around Physical Activity in Patients Type 1 Diabetes
by: Sémah Tagougui, et al.
Published: (2019-01-01)

Associations of Insulin Levels and Insulin Resistance With Urine Glucose Excretion Independent of Blood Glucose in Chinese Adults With Prediabetes and Newly Diagnosed Diabetes
by: Juan Chen, et al.
Published: (2018-11-01)

Cannot write session to /tmp/vufind_sessions/sess_9m2cl8k43akr2hbhcfhn783mms